Boaz Weinstein sold $502K of abrdn Life Sciences Investors (HQL)

Executed Feb 12 2025, disclosed Feb 13 2025, 1 day later.

Value, as filed

$502K

36,536 sh × $13.75

Executed

Feb 12 2025

the trade date, as filed

Disclosed

Feb 13 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BW Boaz Weinstein 10% owner profile →

Boaz Weinstein (10% owner) filed 253 Form 4 reports in the past 24 months (107 purchases, 146 sales, 5 filed past the two-business-day deadline), most often in BlackRock Capital Allocation Term Trust (BCAT). Across 30 priced purchase filings, the average 21-session return was +3.7% from execution and +2.7% from disclosure (delay-adjusted; derived). The largest single filing was $20.2M of PDX (731,721 sh × $27.60, as filed), executed Jan 13 2025.

The name

HQL HQL HQL · 21 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Boaz Weinstein in HQL

HQLSALE abrdn Life Sciences Investors $198K
14,083 sh × $14.04
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $330K
23,723 sh × $13.89
Exec Aug 29 2025
Filed Sep 2 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $145K
11,419 sh × $12.71
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $287K
23,729 sh × $12.08
Exec May 15 2025
Filed May 19 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $108K
9,144 sh × $11.78
Exec Apr 17 2025
Filed Apr 21 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $126K
10,321 sh × $12.23
Exec Apr 3 2025
Filed Apr 7 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $577K
46,723 sh across 2 lots
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET HQLSALE abrdn Life Sciences Investors $525K
36,978 sh across 2 lots
Exec Jan 30 2025
Filed Feb 3 2025 · 5:30 PM ET